Elaine Kan

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge (2006)

Srivastava, Indresh K, Kan, Elaine, Sun, Yide, Legg, Harold, Lee, Queency, Burke, Brian, ...

No abstract available.

Approaches to Target Conserved Conformational Epitopes in HIV Envelope (2005)

Srivastava, Indresh K, Sharma, Victoria, Kan, Elaine, Sun, Yide, Lian, Ying, Connolly, Michael, ...

No abstract available.

Evaluation of envelope vaccines derived from the South African subtype C Human Immunodeficiency Virus Type 1 TV1 strain (2005)

Lian, Ying, Srivastava, Indresh, Gomez-Roman, V.R., Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...

This article was written by Prof Janse van Rensburg before she joined the University of Pretoria.

Evaluation of envelope vaccines derived from the South African subtype C Human Immunodeficiency Virus Type 1 TV1 strain (2005)

Lian, Ying, Srivastava, Indresh, Gomez-Roman, V.R., Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...

This article was written by Prof Janse van Rensburg before she joined the University of Pretoria.

Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency Virus

Srivastava, Indresh K., Stamatatos, Leonidas, Legg, Harold, Kan, Elaine, Fong, Anne, Coates, Stephen R., ...

Human immunodeficiency virus (HIV) continues to be a major public health problem throughout the world, with high levels of mortality and morbidity associated with AIDS. Considerable efforts to...

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

Srivastava, Indresh K., Stamatatos, Leonidas, Kan, Elaine, Vajdy, Michael, Lian, Ying, Hilt, Susan, ...

The envelope (Env) glycoprotein of human immunodeficiency virus type 1 (HIV-1) is the major target of neutralizing antibody responses and is likely to be a critical component of an effective vaccine...

Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies

Peng, Bo, Wang, Liqun Rejean, Gómez-Román, Victor Raúl, Davis-Warren, Alberta, Montefiori, David C., Kalyanaraman, V. S., ...

A major challenge in combating the human immunodeficiency virus (HIV) epidemic is the development of vaccines capable of inducing potent, persistent cellular immunity and broadly reactive...

Evaluation of Envelope Vaccines Derived from the South African Subtype C Human Immunodeficiency Virus Type 1 TV1 Strain

Lian, Ying, Srivastava, Indresh, Gómez-Román, V. Rául, Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...

Human immunodeficiency virus type 1 (HIV-1) subtype C infections are on the rise in Sub-Saharan Africa and Asia. Therefore, there is a need to develop an HIV vaccine capable of eliciting broadly...

Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency Virus

Srivastava, Indresh K., Stamatatos, Leonidas, Legg, Harold, Kan, Elaine, Fong, Anne, Coates, Stephen R., ...

Human immunodeficiency virus (HIV) continues to be a major public health problem throughout the world, with high levels of mortality and morbidity associated with AIDS. Considerable efforts to...

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

Srivastava, Indresh K., Stamatatos, Leonidas, Kan, Elaine, Vajdy, Michael, Lian, Ying, Hilt, Susan, ...

The envelope (Env) glycoprotein of human immunodeficiency virus type 1 (HIV-1) is the major target of neutralizing antibody responses and is likely to be a critical component of an effective vaccine...

Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies

Peng, Bo, Wang, Liqun Rejean, Gómez-Román, Victor Raúl, Davis-Warren, Alberta, Montefiori, David C., Kalyanaraman, V. S., ...

A major challenge in combating the human immunodeficiency virus (HIV) epidemic is the development of vaccines capable of inducing potent, persistent cellular immunity and broadly reactive...

Evaluation of Envelope Vaccines Derived from the South African Subtype C Human Immunodeficiency Virus Type 1 TV1 Strain

Lian, Ying, Srivastava, Indresh, Gómez-Román, V. Rául, Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...

Human immunodeficiency virus type 1 (HIV-1) subtype C infections are on the rise in Sub-Saharan Africa and Asia. Therefore, there is a need to develop an HIV vaccine capable of eliciting broadly...

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge

Srivastava, Indresh K, Kan, Elaine, Sun, Yide, Legg, Harold, Lee, Queency, Burke, Brian, ...

Antibody Responses Elicited in Macaques Immunized with Human Immunodeficiency Virus Type 1 (HIV-1) SF162-Derived gp140 Envelope Immunogens: Comparison with Those Elicited during Homologous Simian/Human Immunodeficiency Virus SHIVSF162P4 and Heterologous HIV-1 Infection†

Derby, Nina R., Kraft, Zane, Kan, Elaine, Crooks, Emma T., Barnett, Susan W., Srivastava, Indresh K., ...

The antibody responses elicited in rhesus macaques immunized with soluble human immunodeficiency virus (HIV) Env gp140 proteins derived from the R5-tropic HIV-1 SF162 virus were analyzed and compared...

Antibody Responses Elicited in Macaques Immunized with Human Immunodeficiency Virus Type 1 (HIV-1) SF162-Derived gp140 Envelope Immunogens: Comparison with Those Elicited during Homologous Simian/Human Immunodeficiency Virus SHIVSF162P4 and Heterologous HIV-1 Infection

Derby, Nina R., Kraft, Zane, Kan, Elaine, Crooks, Emma T., Barnett, Susan W., Srivastava, Indresh K., ...